PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmidmBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Medical Informatics and Decision Making
 
BMC Med Inform Decis Mak. 2012; 12: 58.
Published online 2012 June 27. doi:  10.1186/1472-6947-12-58
PMCID: PMC3488968
A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy
Jing Gao,1 Yong Wang,2 Zhennan Dong,1 Zhangming Yan,3 Xingwang Jia,1 and Yaping Tiancorresponding author1
1Department of Clinical Biochemistry, State Key Laboratory of Kidney Disease, Chinese PLA General Hospital, Beijing, 100853, China
2Division of Nephropathy, State Key Laboratory of Kidney Disease, Chinese PLA General Hospital, Beijing, 100853, China
3School of Life Sciences, Tsinghua University, Beijing, 100084, China
corresponding authorCorresponding author.
Jing Gao: gaojingwang/at/yahoo.cn; Yong Wang: wangyong301/at/263.net; Zhennan Dong: dongzn/at/301hospital.com.cn; Zhangming Yan: yzm09/at/mails.tsinghua.edu.cn; Xingwang Jia: jiaxingw301/at/yahoo.com.cn; Yaping Tian: tianyp61/at/gmail.com
Received October 23, 2011; Accepted June 27, 2012.
Abstract
Background
Immunoglobulin A nephropathy (IgAN) is the most common form of glomerulonephritis in China. An accurate diagnosis of IgAN is dependent on renal biopsies, and there is lack of non-invasive and practical classification methods for discriminating IgAN from other primary kidney diseases. The objective of this study was to develop a classification model for the auxiliary diagnosis of IgAN using multiparameter analysis with various biological parameters.
Methods
To establish an optimal classification model, 121 cases (58 IgAN vs. 63 non-IgAN) were recruited and statistically analyzed. The model was then validated in another 180 cases.
Results
Of the 57 biological parameters, there were 16 parameters that were significantly different (P < 0.05) between IgAN and non-IgAN. The combination of fibrinogen, serum immunoglobulin A level, and manifestation was found to be significant in predicting IgAN. The validation accuracies of the logistic regression and discriminant analysis models were 77.5 and 77.0%, respectively at a predictive probability cut-off of 0.5, and 81.1 and 79.9%, respectively, at a predictive probability cut-off of 0.40. When the predicted probability of the equation containing the combination of fibrinogen, serum IgA level, and manifestation was more than 0.59, a patient had at least an 85.0% probability of having IgAN. When the predicted probability was lower than 0.26, a patient had at least an 88.5% probability of having non-IgAN. The results of the net reclassification improvement certificated serum Immunoglobulin A and fibrinogen had classification power for discriminating IgAN from non-IgAN.
Conclusions
These models possess potential clinical applications in distinguishing IgAN from other primary kidney diseases.
Keywords: Primary kidney disease, IgA nephropathy, Multiparameter analysis
Articles from BMC Medical Informatics and Decision Making are provided here courtesy of
BioMed Central